Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Clin. transl. oncol. (Print) ; 23(8): 1657-1665, ago. 2021. graf
Artigo em Inglês | IBECS | ID: ibc-222164

RESUMO

Purpose RENORT is a novel data mining application developed to extract relevant clinical data from oncology information systems (OIS; ARIA and Mosaiq) used in radiation oncology (RO). Methods/patients We used RENORT to extract demographic and clinical data from the OIS of all patients treated at the RO Department at the General Hospital of Valencia during the year 2019. Results A total of 1158 treatments were performed. The female/male ratio was 39.3%/60.7%, with a mean age of 66 years. The mean waiting time between the treatment decision/proposal to the first visit was 10.1 days. Mean duration of the treatment preparation process was 21 days. Most patients (90.4%) completed treatment within the prescribed time ± 7 days. The most common sites/treatment types were: metastatic/palliative treatments (n = 300; 25.9%), breast (209; 18.0%), genitourinary (195; 16.8%), digestive (116; 10.0%), thoracic (104; 9.0%), head and neck (62; 5.4%), and skin cancer (51; 4.4%). The distribution according to treatment intent was as follows: palliative (n = 266; 23.0%), adjuvant curative (335; 28.9%), radical without adjuvant treatment (229; 19.8%), radical with concomitant treatment (188; 16.2%), curative neoadjuvant (70; 6.0%), salvage radiotherapy (61; 5.3%); and reirradiation (9; 0.8%). The most common treatment techniques were IMRT/VMAT with IGRT (n = 468; 40.4%), 3D-CRT with IGRT (421; 36.4%), SBRT (127; 11.0%), 2DRT (57; 4.9%), and SFRT (56; 4.8%). A mean of 15.9 fractions were administered per treatment. Hypofractionated schemes were used in 100% of radical intent breast and prostate cancer treatments. Conclusions The RENORT application facilitates data retrieval from oncology information systems to allow for a comprehensive determination of the real role of radiotherapy in the treatment of cancer patients. This application is valuable to identify patterns of care and to assess treatment efficacy (AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Mineração de Dados/métodos , Metástase Neoplásica/radioterapia , Neoplasias/radioterapia , Radioterapia (Especialidade)/estatística & dados numéricos , Distribuição por Idade , Fracionamento da Dose de Radiação , Hospitais Universitários , Cuidados Paliativos/estatística & dados numéricos , Radioterapia/métodos , Radioterapia/estatística & dados numéricos , Terapia de Salvação/estatística & dados numéricos , Tempo para o Tratamento/estatística & dados numéricos
2.
Clin Transl Oncol ; 23(8): 1657-1665, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33586123

RESUMO

PURPOSE: RENORT is a novel data mining application developed to extract relevant clinical data from oncology information systems (OIS; ARIA and Mosaiq) used in radiation oncology (RO). METHODS/PATIENTS: We used RENORT to extract demographic and clinical data from the OIS of all patients treated at the RO Department at the General Hospital of Valencia during the year 2019. RESULTS: A total of 1158 treatments were performed. The female/male ratio was 39.3%/60.7%, with a mean age of 66 years. The mean waiting time between the treatment decision/proposal to the first visit was 10.1 days. Mean duration of the treatment preparation process was 21 days. Most patients (90.4%) completed treatment within the prescribed time ± 7 days. The most common sites/treatment types were: metastatic/palliative treatments (n = 300; 25.9%), breast (209; 18.0%), genitourinary (195; 16.8%), digestive (116; 10.0%), thoracic (104; 9.0%), head and neck (62; 5.4%), and skin cancer (51; 4.4%). The distribution according to treatment intent was as follows: palliative (n = 266; 23.0%), adjuvant curative (335; 28.9%), radical without adjuvant treatment (229; 19.8%), radical with concomitant treatment (188; 16.2%), curative neoadjuvant (70; 6.0%), salvage radiotherapy (61; 5.3%); and reirradiation (9; 0.8%). The most common treatment techniques were IMRT/VMAT with IGRT (n = 468; 40.4%), 3D-CRT with IGRT (421; 36.4%), SBRT (127; 11.0%), 2DRT (57; 4.9%), and SFRT (56; 4.8%). A mean of 15.9 fractions were administered per treatment. Hypofractionated schemes were used in 100% of radical intent breast and prostate cancer treatments. CONCLUSIONS: The RENORT application facilitates data retrieval from oncology information systems to allow for a comprehensive determination of the real role of radiotherapy in the treatment of cancer patients. This application is valuable to identify patterns of care and to assess treatment efficacy.


Assuntos
Mineração de Dados/métodos , Neoplasias/radioterapia , Radioterapia (Especialidade)/estatística & dados numéricos , Distribuição por Idade , Idoso , Fracionamento da Dose de Radiação , Feminino , Hospitais Universitários , Humanos , Masculino , Metástase Neoplásica/radioterapia , Cuidados Paliativos/estatística & dados numéricos , Radioterapia/métodos , Radioterapia/estatística & dados numéricos , Radioterapia Adjuvante/estatística & dados numéricos , Reirradiação/estatística & dados numéricos , Terapia de Salvação/estatística & dados numéricos , Distribuição por Sexo , Espanha , Tempo para o Tratamento/estatística & dados numéricos
3.
Clin Transl Oncol ; 23(3): 481-490, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32621208

RESUMO

PURPOSE: To assess the pattern of treatment failure in patients with prostate cancer (PCa) treated with radiotherapy (76-80 Gy) ± hormone therapy (HT). We also evaluated the influence of treatment failure on survival outcomes. METHODS: Retrospective study of patients with PCa (n = 302) treated with radiotherapy (RT) ± HT at our centre between November 1999 and July 2007. The mean patient age was 70.2 years (range 51-87). Distribution by NCCN risk group was low (n = 80, 26.5%), intermediate (n = 86, 28.5%), high (n = 77, 25.5%), and very high (n = 49, 16.2%). Most patients (n = 273, 90.4%) received IMRT at a dose of 76-80 Gy. HT was administered in 237 patients (78.5%), in most cases (n = 167, 55.3%) for < 7 months RESULTS: Survival rates at 10 years were: overall survival (OS), 64.3%; biochemical disease-free survival, 83.9%; disease-free survival, 92.5%; and metastasis-free survival (MFS), 94.3%. Biochemical failure (BF) was observed in 55 cases (18.2%), 32 of whom subsequently developed clinical recurrence: metastasis (n = 17, 5.6%), local failure (n = 11, 3.6%), and regional failure (n = 4, 1.3%). The cause of death (n = 159) was intercurrent disease in 115 cases (72.3%), second cancer in 27 (17.0%), and PCa in 17 (10.7%). Biochemical failure-free survival ≤ 24 months was significantly associated with worse OS and MFS (p = 0.0001). Late genitourinary and gastrointestinal toxicity grade ≥ 3 (RTOG) was observed in 18 (6.0%) and 7 (2.3%) patients, respectively. CONCLUSIONS: The main type of treatment failure after 76-80 Gy of radiotherapy ± HT is local or metastatic. In all cases, biochemical failure occurred prior to treatment failure. BF within 24 months of treatment completion was significantly associated with worse OS and MFS.


Assuntos
Próstata/efeitos da radiação , Neoplasias da Próstata/radioterapia , Glândulas Seminais/efeitos da radiação , Idoso , Idoso de 80 Anos ou mais , Causas de Morte , Terapia Combinada , Intervalo Livre de Doença , Humanos , Calicreínas/sangue , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/sangue , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/sangue , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/mortalidade , Dosagem Radioterapêutica , Radioterapia de Intensidade Modulada/efeitos adversos , Radioterapia de Intensidade Modulada/métodos , Estudos Retrospectivos , Taxa de Sobrevida , Falha de Tratamento
4.
Clin. transl. oncol. (Print) ; 16(10): 892-897, oct. 2014.
Artigo em Inglês | IBECS | ID: ibc-127608

RESUMO

INTRODUCTION: Radiotherapy (RT) is an essential part of the patient's treatment diagnosed with cancer. Determination of the most common RT secondary effect, the cutaneous toxicity, is usually based on visual rating scales, like Common Terminology Criteria for Adverse Events with an inherent subjectivity. The aim of this work is to perform an objective method to evaluate the radiodermatitis using a non-invasive imaging technique based on laser Doppler flowmetry (LDF). MATERIALS AND METHODS: A prospective study was performed analysing 1,824 measurements. A LDF was used to measure the cutaneous microcirculation in real time. A basal measurement was taken prior to radiotherapy treatment. To be able to observe the microcirculation changes related to the delivered dose, several sets of measurements were taken in the irradiated area along the RT treatment and in the contralateral non-irradiated area. RESULTS: A relative increase in blood flow at all measured points was found in the irradiated area. This relative increase in blood flow increases with the dose administered. In the non-irradiated contralateral area, the relative increase in blood flow is not significant and is independent of the dose administered. After treatment, a decrease in blood flow was detected with a trend towards returning to the baseline measurements. CONCLUSIONS: LDF is an objective technique that assesses early radiodermatitis. This method is useful to develop strategies to prevent onset of radiation dermatitis in patients irradiated, such as the modification and individualization of fractionation parameters of the RT. This allows the reduction of radiation morbidities and maintains patient quality of life (AU)


No disponible


Assuntos
Humanos , Masculino , Feminino , Neoplasias/radioterapia , Radiodermatite/complicações , Radiodermatite/diagnóstico , Radiodermatite/tratamento farmacológico , Radioterapia/métodos , Radioterapia/tendências , Radioterapia , Reologia/estatística & dados numéricos , Fluxometria por Laser-Doppler/métodos , Fluxometria por Laser-Doppler/tendências , Estudos Prospectivos , Microcirculação , Microcirculação/efeitos da radiação
5.
Clin Transl Oncol ; 16(10): 892-7, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24643699

RESUMO

INTRODUCTION: Radiotherapy (RT) is an essential part of the patient's treatment diagnosed with cancer. Determination of the most common RT secondary effect, the cutaneous toxicity, is usually based on visual rating scales, like Common Terminology Criteria for Adverse Events with an inherent subjectivity. The aim of this work is to perform an objective method to evaluate the radiodermatitis using a non-invasive imaging technique based on laser Doppler flowmetry (LDF). MATERIALS AND METHODS: A prospective study was performed analysing 1,824 measurements. A LDF was used to measure the cutaneous microcirculation in real time. A basal measurement was taken prior to radiotherapy treatment. To be able to observe the microcirculation changes related to the delivered dose, several sets of measurements were taken in the irradiated area along the RT treatment and in the contralateral non-irradiated area. RESULTS: A relative increase in blood flow at all measured points was found in the irradiated area. This relative increase in blood flow increases with the dose administered. In the non-irradiated contralateral area, the relative increase in blood flow is not significant and is independent of the dose administered. After treatment, a decrease in blood flow was detected with a trend towards returning to the baseline measurements. CONCLUSIONS: LDF is an objective technique that assesses early radiodermatitis. This method is useful to develop strategies to prevent onset of radiation dermatitis in patients irradiated, such as the modification and individualization of fractionation parameters of the RT. This allows the reduction of radiation morbidities and maintains patient quality of life.


Assuntos
Fluxometria por Laser-Doppler , Microcirculação , Neoplasias/radioterapia , Radiodermatite/diagnóstico , Pele/irrigação sanguínea , Relação Dose-Resposta à Radiação , Humanos , Estudos Prospectivos , Reprodutibilidade dos Testes , Índice de Gravidade de Doença
6.
Clin. transl. oncol. (Print) ; 15(1): 39-45, ene. 2013. tab, ilus
Artigo em Inglês | IBECS | ID: ibc-126966

RESUMO

INTRODUCTION: In breast IMRT simultaneous integrated boost (SIB) treatment and accelerated partial breast irradiation (APBI), proper delineation of the tumor bed is necessary. Conservative oncoplastic surgery causes changes in peritumoral breast tissue that complicates locating the site of the tumor. Nevertheless, there are still centers that do not use surgical clips to delineate the site. This study aims to show how the lack of clips affects the techniques of SIB and APBI in terms of dose distribution and safety margins in the tumor bed. MATERIALS AND METHODS: On 30 patients, the defining of the tumor bed obtained from the pre-surgery CT scan to that outlined on the basis of clips on the post-surgery CT was compared. Tumor bed deviation from the original tumor site was quantified. In addition, the margins to the original tumor site necessary to guarantee the coverage of the tumor bed were calculated. RESULTS: Variations were detected in the distances between geometric centers of the PTV (minimum 0.5-maximum 3 cm). The maximum margin necessary to include the entire tumor bed was 4.5 cm. Lesions located in the upper outer quadrant required the widest margins. If margins are not added, the tumor bed volume defined with clips will be underdosed. CONCLUSIONS: The definition of the tumor bed based on studies before surgery does not have the necessary accuracy. Clips need to be placed in the surgical bed to identify the changes occurring after the restorative mammoplasty. Without clips, SIB and APBI are not safe (AU)


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Mama/patologia , Mama/efeitos da radiação , Mama/cirurgia , Mastectomia Segmentar/métodos , Planejamento da Radioterapia Assistida por Computador , Neoplasias da Mama/radioterapia , Neoplasias da Mama/cirurgia , Estudos Prospectivos , Radioterapia
7.
Rev Neurol ; 52(5): 275-82, 2011 Mar 01.
Artigo em Espanhol | MEDLINE | ID: mdl-21341222

RESUMO

INTRODUCTION AND AIM: Radiosurgery is among the treatment options for patients with vestibular schwannoma. We present the experience in our institution in the treatment of this disease with this technique. PATIENTS AND METHODS: A retrospective study was made including 20 patients (11 women and 9 men; median age: 55.15 years-old) with vestibular schwannoma who received linear accelerator radiosurgery treatment since April 2005 until December 2008. Follow-up period was between 12 and 42 months, considering clinical examination of cranial nerves VII (House-Brackmann scale) and VIII (Gardner-Robertson scale) as well as radiological findings (considering tumor volume). For statistical analysis, the Fisher's exact test and logistic regression test were used. RESULTS: Certain worsening of hearing function was present in 25% of the patients. Five patients had large tumors at the moment of the treatment (equal or larger than 3.5 cm3), from which four deteriorated from headache, unsteady gait, dizziness/vertigo, facial numbness and tinnitus, with statistical significance (p < 0.05). From the first year of treatment on, there was a tumor volume decrease tendency, with no tumor growth in the medium/long term follow-up, achieving a local control rate of 100%. CONCLUSIONS: Radiosurgery has become an alternative in the treatment of patients with vestibular schwannoma of appropriate size, with high safety level, using low radiation doses, low rate of complications and good tumor control rate in the medium term follow-up.


Assuntos
Neuroma Acústico/cirurgia , Radiocirurgia/métodos , Adulto , Idoso , Nervo Facial/fisiologia , Nervo Facial/fisiopatologia , Nervo Facial/cirurgia , Feminino , Audição/fisiologia , Testes Auditivos , Humanos , Masculino , Pessoa de Meia-Idade , Neuroma Acústico/patologia , Estudos Retrospectivos , Resultado do Tratamento , Nervo Vestibulococlear/fisiologia , Nervo Vestibulococlear/fisiopatologia , Nervo Vestibulococlear/cirurgia
8.
Oncología (Barc.) ; 25(2): 102-106, feb. 2002. ilus, graf
Artigo em Es | IBECS | ID: ibc-5300

RESUMO

Introducción: En algunos tratamientos especiales, tales como la radiocirugía, una diferencia de unos pocos milímetros en los contornos de las isodosis pueden conducir a tomar una estrategia de tratamiento diferente, por lo que un cálculo preciso resulta imprescindible. Esto es particularmente importante cerca de inhomogeneidades, debido a la ausencia de equilibrio electrónico. La simulación con Monte Carlo supera esta imprecisión pero a expensas de un elevado tiempo de CPU. Nuestro trabajo ha ido enfocado a la optimización de los recursos reduciendo el tiempo de computación.Material y Método: Se ha desarrollado un modelo de distribución para la simulación de tratamientos de radiocirugía sobre un cluster de PCs. Un PC servidor exporta el código MC y los datos de entrada a los nodos clientes, almacenando finalmente los resultados. Además, este modelo distribuye las tareas individuales desde un punto de vista clínico y físico por lo que, no solo se reduce el tiempo de CPU sino que se alcanza un análisis detallado del tratamiento. Para la simulación, se ha utilizado el código EGS4 operando bajo UNÍX e integrado en el paquete OMEGA-BEAM. En colaboración con la Escuela de Ingenieros de la Universidad de Sevilla, el modelo ha sido instalado en una red local de 36 PCs.Resultados: Tratamientos de radiocirugia complejos fueron simulados usando este modelo, empleando tiempo inferiores a la hora. Los resultados obtenidos con el planificador convencional y con MC coinciden en la mayoría de los casos convencionales. Sin embargo, muestran diferencias de hasta el 30 por ciento en algunas isodosis cuando entran en juego inhomogeneidades, implícitas en situaciones complejas.Conclusiones: Por tanto, una buena utilización de los recursos disponibles pueden convertir a la simulación con MC en una alternativa abordable por cualquier institución sin un gran coste adicional. Esta accesibilidad y operatividad gracias a la reducción sustancial en el tiempo de procesamiento, presentan a la simulación con MC como una herramienta eficaz para la verificación de tratamientos (AU)


Assuntos
Humanos , Radiocirurgia/métodos , Método de Monte Carlo , Modelos Teóricos , 28574
9.
Oncología (Barc.) ; 25(2): 107-116, feb. 2002. ilus, graf
Artigo em Es | IBECS | ID: ibc-5301

RESUMO

En radiocirugía la dosimetría física y clínica es más compleja que en técnicas radioterápicas de campos más extensos. Además, los planificadores convencionales, a pesar de su eficacia, mantienen ciertas incertidumbres. Por ello, la aparición de códigos basados en Monte Carlo tales como BEAM supone una alternativa al problema. Una vez simulado el acelerador se obtiene la información del haz de radiación, la cual puede ser analizada obteniéndose energías medias o distribuciones espectrales. Mediante el programa DOSXYZ, se consiguen distribuciones de dosis, tanto en fantomas como en pacientes. Este trabajo consiste en una serie de prácticas mediante las cuales se pretende conseguir un cierto manejo del paquete OMEGA que incluye los códigos BEAM y DOSXYZ. También se obtienen los Histogramas Dosis-Volumen calculados por Monte Carlo, mediante un programa desarrollado por nuestro grupo y se comparan con los dados por el planificador (AU)


Assuntos
Humanos , Dosimetria , Método de Monte Carlo , Cinerradiografia , Radiocirurgia/métodos , 28574 , Aceleradores de Partículas
10.
Oncología (Barc.) ; 25(2): 121-129, feb. 2002. tab, ilus
Artigo em Es | IBECS | ID: ibc-5303

RESUMO

El rápido desarrollo de los distintos tipos de imagen y su gran variedad de formatos hacen que se presenten muchas veces problemas de compatibilidad entre los diferentes sistemas. En el presente trabajo se trata de analizar las citadas imágenes y establecer procedimientos para compatibilizar los diferentes formatos. Por otra parte se aborda el problema de la corrección por software de la deformación geométrica producida por diferentes sistemas de imagen a partir del estudio de la deformación producida en la imagen de un objeto de geometría simple y conocida y se presenta un algoritmo capaz de corregir la citada deformación (AU)


Assuntos
Humanos , Radiocirurgia/métodos , Processamento de Imagem Assistida por Computador/métodos , Planejamento da Radioterapia Assistida por Computador , Algoritmos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...